Expression of B7, C1QA, CD4, CD8A, IL10, IL15, IL18BP, SERPINE1, TNF, and TNFSF6 were normalized compared to unstable RA patients maintained on DMARD therapy (Figures 1A,B). Here, IL18BP is linked to rheumatoid arthritis.